{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:30:30Z","timestamp":1791232230225,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.yebeh.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T14:08:39Z","timestamp":1123682919000},"page":"1-64","source":"Crossref","is-referenced-by-count":145,"special_numbering":"S1","title":["Treatment of epilepsy in adults: expert opinion, 2005"],"prefix":"10.1016","volume":"7","author":[{"given":"Steven","family":"Karceski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha J.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2005.06.001_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2165\/00003495-199346010-00009","article-title":"Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy","volume":"46","author":"Goa","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2005.06.001_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1528-1157.1994.tb02513.x","article-title":"Gabapentin as add-on therapy in patients with partial seizures: a double-blind placebo-controlled study","volume":"35","author":"Anhut","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib3","doi-asserted-by":"crossref","unstructured":"US Gabapentin Study Group. Gabapentin as add-on therapy in refractory epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292\u20138.","DOI":"10.1212\/WNL.43.11.2292"},{"key":"10.1016\/j.yebeh.2005.06.001_bib4","series-title":"Epilepsy: a comprehensive textbook","first-page":"1541","article-title":"Oxcarbazepine","author":"Gram","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib5","series-title":"Epilepsy: a comprehensive textbook","first-page":"1593","article-title":"Topiramate","author":"Kramer","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib6","doi-asserted-by":"crossref","unstructured":"Sachdeo RC, Leroy RF, Krauss GL, Drake ME Jr, Green PM, Leppik IE, Shu VS, Ringham GL, Sommerville KW. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Arch Neurol 1997;54:595\u2013601.","DOI":"10.1001\/archneur.1997.00550170069016"},{"key":"10.1016\/j.yebeh.2005.06.001_bib7","series-title":"Epilepsy: a comprehensive textbook","first-page":"1509","article-title":"Felbamate","author":"Theodore","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2005.06.001_bib9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1999.tb00913.x","article-title":"Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs","volume":"40","author":"White","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/14656566.1.1.49","article-title":"New formulations of drugs in epilepsy","volume":"1","author":"Wheless","year":"1999","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2005.06.001_bib11","series-title":"Epilepsy: a comprehensive textbook","first-page":"1353","article-title":"Vagal nerve stimulation","author":"Wilder","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib12","series-title":"Epilepsy: a comprehensive textbook","first-page":"1334","article-title":"Ketogenic diet","author":"Vining","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1059-1311(02)00287-X","article-title":"Use of clobazam for the treatment of refractory complex partial seizures","volume":"12","author":"Shmizu","year":"2003","journal-title":"Seizure"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.2001.042suppl.3027.x","article-title":"Management strategies for localization-related seizures","volume":"42","author":"Brodie","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib15","doi-asserted-by":"crossref","unstructured":"Montenegro MA, Cendes F, Noronha AL, Mory SB, Carvalho MI, Marques LH, Guerreiro CA. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy. Epilepsia 2001;42:539\u201342.","DOI":"10.1046\/j.1528-1157.2001.31600.x"},{"key":"10.1016\/j.yebeh.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/08830738040190090801","article-title":"Managing epilepsy in tuberous sclerosis","volume":"19","author":"Thiele","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM200108023450501","article-title":"Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized controlled trial of surgery for temporal lobe epilepsy","volume":"345","author":"Wiebe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2005.06.001_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11910-004-0058-9","article-title":"Early epilepsy surgery","volume":"4","author":"Wiebe","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2005.06.001_bib19","doi-asserted-by":"crossref","unstructured":"Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA; Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475\u201380.","DOI":"10.1212\/01.WNL.0000150932.48688.BE"},{"key":"10.1016\/j.yebeh.2005.06.001_bib20","doi-asserted-by":"crossref","unstructured":"Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S; Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20\u20137.","DOI":"10.1111\/j.0013-9580.2004.31203.x"},{"key":"10.1016\/j.yebeh.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/j.1528-1157.1999.tb00919.x","article-title":"Evidence-based medicine and antiepileptic drugs","volume":"40","author":"Privitera","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2753.2000.00236.x","article-title":"Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials","volume":"6","author":"Williamson","year":"2000","journal-title":"J Eval Clin Pract"},{"issue":"Suppl.","key":"10.1016\/j.yebeh.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1006\/ebeh.2001.0283","article-title":"The expert consensus guideline series: treatment of epilepsy","volume":"2","author":"Karceski","year":"2001","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2005.06.001_bib25","first-page":"631","article-title":"Consensus methods in practice guideline development: A review and description of a new method","volume":"33","author":"Kahn","year":"1997","journal-title":"Psychpharmacol Bull"},{"key":"10.1016\/j.yebeh.2005.06.001_bib26","unstructured":"Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corp.; 1969. Publication # RM-58888 PR."},{"key":"10.1016\/j.yebeh.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archinte.1992.00400170036007","article-title":"Practice guidelines, a new reality in medicine","volume":"152","author":"Woolfe","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2005.06.001_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0266462300002774","article-title":"A method for the detailed assessment of the appropriateness of medical technologies","volume":"2","author":"Brook","year":"1986","journal-title":"Int J Tech Assess Health Care"},{"key":"10.1016\/j.yebeh.2005.06.001_bib29","first-page":"1023","article-title":"A new method of developing expert consensus practice guidelines","volume":"4","author":"Frances","year":"1998","journal-title":"Am J Manag Care"},{"issue":"Suppl. 12a","key":"10.1016\/j.yebeh.2005.06.001_bib30","first-page":"1","article-title":"The expert consensus guideline series: treatment of bipolar disorder","volume":"57","author":"Kahn","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 12b","key":"10.1016\/j.yebeh.2005.06.001_bib31","first-page":"1","article-title":"The expert consensus guideline series: treatment of schizophrenia","volume":"57","author":"McEvoy","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2005.06.001_bib32","first-page":"1","article-title":"The expert consensus guideline series: treatment of obsessive-compulsive disorder","volume":"58","author":"March","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2005.06.001_bib33","unstructured":"Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter D. The expert consensus guideline series: treatment of agitation in older persons with dementia. Postgrad Med Special Report 1998;April:1\u201388."},{"issue":"Suppl. 11","key":"10.1016\/j.yebeh.2005.06.001_bib34","first-page":"1","article-title":"The expert consensus guideline series: treatment of schizophrenia 1999","volume":"60","author":"McEvoy","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 16","key":"10.1016\/j.yebeh.2005.06.001_bib35","first-page":"1","article-title":"The expert consensus guideline series: treatment of posttraumatic stress disorder","volume":"60","author":"Foa","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2005.06.001_bib36","first-page":"159","article-title":"Expert consensus guideline series: treatment of psychiatric and behavioral problems in mental retardation","volume":"105","author":"Rush","year":"2000","journal-title":"Am J Mental Retardation"},{"key":"10.1016\/j.yebeh.2005.06.001_bib37","unstructured":"Sachs GS, Printz DJ, Kahn DA, Carpenter D. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Special Report 2000;Apr;1\u2013104."},{"key":"10.1016\/j.yebeh.2005.06.001_bib38","unstructured":"Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP. The expert consensus guideline series: treatment of depression in women 2001. Postgrad Med Special Report 2001;March:1\u2013115."},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2005.06.001_bib39","first-page":"S1","article-title":"Expert consensus guideline series: treatment of attention-deficit\/hyperactivity disorder","volume":"4","author":"Conners","year":"2001","journal-title":"J Atten Disord"},{"key":"10.1016\/j.yebeh.2005.06.001_bib40","unstructured":"Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP. The expert consensus guideline series: treatment of behavioral emergencies. Postgrad Med Special Report 2001;May:1\u201388."},{"key":"10.1016\/j.yebeh.2005.06.001_bib41","unstructured":"Alexopoulos GS, Katz IR, Reynolds CF, Carpenter D, Docherty JP. The expert consensus guideline series: treatment of depressive disorders in older patients. Postgrad Med Special Report 2001;October:1\u201386."},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2005.06.001_bib42","first-page":"5","article-title":"Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders","volume":"63","author":"Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2005.06.001_bib43","first-page":"1","article-title":"The expert consensus guideline series: using antipsychotic agents in older patients","volume":"65","author":"Alexopulos","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2005.06.001_bib44","unstructured":"Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: treatment of bipolar disorder 2004. Postgrad Med Special Report 2004;December:1\u2013120."},{"key":"10.1016\/j.yebeh.2005.06.001_bib45","unstructured":"Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: treatment of dementia and its behavioral disturbances. Postgrad Med Special Report 2005;January:1\u2013111."},{"key":"10.1016\/j.yebeh.2005.06.001_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.26.8.788","article-title":"Prognostic factors in absence seizures","volume":"26","author":"Sato","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2005.06.001_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003495-199651030-00005","article-title":"Diagnosis and treatment of epilepsy in childhood and adolescents","volume":"51","author":"Morton","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2005.06.001_bib48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1542\/peds.79.6.864","article-title":"Benign epilepsy of childhood: a speculation and its ramifications","volume":"79","author":"Freeman","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2005.06.001_bib49","doi-asserted-by":"crossref","unstructured":"French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurology 2004;62:1252\u201360.","DOI":"10.1212\/01.WNL.0000123693.82339.FC"},{"key":"10.1016\/j.yebeh.2005.06.001_bib50","doi-asserted-by":"crossref","unstructured":"French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology 2004;62:1261\u201373.","DOI":"10.1212\/01.WNL.0000123695.22623.32"},{"key":"10.1016\/j.yebeh.2005.06.001_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1528-1157.1998.tb01413.x","article-title":"Lamotrigine and seizure aggravation in severe myoclonic epilepsy","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib52","doi-asserted-by":"crossref","unstructured":"Carrazana EJ, Wheeler SD. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2001;22;56:1424\u20135.","DOI":"10.1212\/WNL.56.10.1424-a"},{"key":"10.1016\/j.yebeh.2005.06.001_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yebeh.2004.04.002","article-title":"Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study","volume":"5","author":"Morris","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2005.06.001_bib54","doi-asserted-by":"crossref","unstructured":"Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, et al. Comparison of carbamazepine phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145\u201351.","DOI":"10.1056\/NEJM198507183130303"},{"key":"10.1016\/j.yebeh.2005.06.001_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"Comparison of valproate and carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic-seizures in adults","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2005.06.001_bib56","doi-asserted-by":"crossref","unstructured":"Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN, Renier WO, Van Rijn CM. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000;41:1364\u201374.","DOI":"10.1111\/j.1528-1157.2000.tb00111.x"},{"key":"10.1016\/j.yebeh.2005.06.001_bib57","doi-asserted-by":"crossref","unstructured":"Genton P, Bauer J, Duncan S, Taylor AE, Balen AH, Eberle A, Pedersen B, Salas-Puig X, Sauer MV. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001;42:295\u2013304.","DOI":"10.1046\/j.1528-1157.2001.28899.x"},{"key":"10.1016\/j.yebeh.2005.06.001_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2005.06.001_bib59","doi-asserted-by":"crossref","unstructured":"Isojarvi JI, Rattya J, Myllyla VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446\u201351.","DOI":"10.1002\/ana.410430406"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2005.06.001_bib60","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/j.1528-1157.1998.tb02605.x","article-title":"Effects of epilepsy on women\u2019s reproductive health","volume":"39","author":"Morrell","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.06.001_bib61","doi-asserted-by":"crossref","unstructured":"Morrell MJ, Giudice L, Flynn KL, Seale CG, Paulson AJ, Done S, Flaster E, Ferin M, Sauer MV. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704\u201311.","DOI":"10.1002\/ana.10391"},{"key":"10.1016\/j.yebeh.2005.06.001_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0025-6196(11)63125-X","article-title":"Acute and chronic seizures in patients older than 60 years","volume":"76","author":"Sirven","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.yebeh.2005.06.001_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002512-200017060-00002","article-title":"Choice of newer anticonvulsant drugs in older patients","volume":"17","author":"Willmore","year":"2000","journal-title":"Drugs Aging"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2005.06.001_bib64","first-page":"S9","article-title":"Epilepsy in the elderly","volume":"55","author":"Ramsay","year":"2000","journal-title":"Neurology"},{"issue":"8 Pt. 2","key":"10.1016\/j.yebeh.2005.06.001_bib65","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1592\/phco.20.12.185S.35253","article-title":"Current discoveries on the cognitive effects of antiepileptic drugs","volume":"20","author":"Meador","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yebeh.2005.06.001_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11910-004-0057-x","article-title":"Special populations: the management of seizures in HIV-positive patients","volume":"4","author":"Mullin","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2005.06.001_bib67","doi-asserted-by":"crossref","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432\u201341.","DOI":"10.4088\/JCP.v65n0321"},{"key":"10.1016\/j.yebeh.2005.06.001_bib68","doi-asserted-by":"crossref","unstructured":"Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013\u201324.","DOI":"10.4088\/JCP.v64n0906"},{"key":"10.1016\/j.yebeh.2005.06.001_bib69","series-title":"Epilepsy: a comprehensive textbook","first-page":"2161","article-title":"Neuropsychiatric consequences of pharmacotherapy","author":"Trimble","year":"1997"},{"key":"10.1016\/j.yebeh.2005.06.001_bib70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(00)03600-X","article-title":"Neuropsychological effects of epilepsy and antiepileptic drugs","volume":"357","author":"Kwan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2005.06.001_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ps.52.5.619","article-title":"Evidence-based pharmacologic treatment for people with severe mental illness: a focus on guidelines and algorithms","volume":"52","author":"Mellman","year":"2001","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.yebeh.2005.06.001_bib72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/01.WNL.0000138590.00074.9A","article-title":"Mortality in epilepsy: driving fatalities vs other causes of death in patients with epilepsy","volume":"63","author":"Sheth","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2005.06.001_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5694\/j.1326-5377.2003.tb05563.x","article-title":"New driving guidelines: ethical and legal uncertainties","volume":"179","author":"Black","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.yebeh.2005.06.001_bib74","doi-asserted-by":"crossref","unstructured":"Drazkowski JF, Fisher RS, Sirven JI, Demaerschalk BM, Uber-Zak L, Hentz JG, Labiner D. Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc 2003;78:819\u201325.","DOI":"10.4065\/78.7.819"},{"key":"10.1016\/j.yebeh.2005.06.001_bib75","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.57.10.1749","article-title":"Driving restrictions and people with epilepsy","volume":"57","author":"Chadwick","year":"2001","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505005002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505005002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:43:27Z","timestamp":1683168207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505005002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":75,"alternative-id":["S1525505005002222"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2005.06.001","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}